These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19540323)

  • 1. The effect of temperature and moisture on the amorphous-to-crystalline transformation of stavudine.
    Strydom S; Liebenberg W; Yu L; de Villiers M
    Int J Pharm; 2009 Sep; 379(1):72-81. PubMed ID: 19540323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.
    Rumondor AC; Marsac PJ; Stanford LA; Taylor LS
    Mol Pharm; 2009; 6(5):1492-505. PubMed ID: 19634917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the moisture sorption behavior of amorphous sucrose using a dynamic humidity generating instrument.
    Yu X; Kappes SM; Bello-Perez LA; Schmidt SJ
    J Food Sci; 2008 Jan; 73(1):E25-35. PubMed ID: 18211350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid state characterization of the anti-HIV drug TMC114: interconversion of amorphous TMC114, TMC114 ethanolate and hydrate.
    Van Gyseghem E; Stokbroekx S; de Armas HN; Dickens J; Vanstockem M; Baert L; Rosier J; Schueller L; Van den Mooter G
    Eur J Pharm Sci; 2009 Dec; 38(5):489-97. PubMed ID: 19782132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical relationships of three solid state forms of stavudine.
    Gandhi RB; Bogardus JB; Bugay DE; Perrone RK; Kaplan MA
    Int J Pharm; 2000 May; 201(2):221-37. PubMed ID: 10878328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moisture sorption, compressibility and caking of lactose polymorphs.
    Listiohadi Y; Hourigan JA; Sleigh RW; Steele RJ
    Int J Pharm; 2008 Jul; 359(1-2):123-34. PubMed ID: 18485633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid state amorphization of pharmaceuticals.
    Willart JF; Descamps M
    Mol Pharm; 2008; 5(6):905-20. PubMed ID: 18954076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and monitoring of pseudo-polymorphs in manufacturing process by NIR.
    Kamada K; Yoshimura S; Murata M; Murata H; Nagai H; Ushio H; Terada K
    Int J Pharm; 2009 Feb; 368(1-2):103-8. PubMed ID: 19007870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of heterogeneous nucleation on the surface crystallization of guaifenesin from melt extrudates containing Eudragit L10055 or Acryl-EZE.
    Bruce CD; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Eur J Pharm Biopharm; 2010 May; 75(1):71-8. PubMed ID: 19995604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An investigation into the influence of counterion on the properties of some amorphous organic salts.
    Towler CS; Li T; Wikström H; Remick DM; Sanchez-Felix MV; Taylor LS
    Mol Pharm; 2008; 5(6):946-55. PubMed ID: 19434850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation and physical stability of the amorphous phase of ranitidine hydrochloride polymorphs prepared by cryo-milling.
    Chieng N; Rades T; Saville D
    Eur J Pharm Biopharm; 2008 Mar; 68(3):771-80. PubMed ID: 17945474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of oral bioavailability of an HIV-attachment inhibitor by nanosizing and amorphous formulation approaches.
    Fakes MG; Vakkalagadda BJ; Qian F; Desikan S; Gandhi RB; Lai C; Hsieh A; Franchini MK; Toale H; Brown J
    Int J Pharm; 2009 Mar; 370(1-2):167-74. PubMed ID: 19100319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Devitrification of amorphous celecoxib.
    Gupta P; Bansal AK
    AAPS PharmSciTech; 2005 Sep; 6(2):E223-30. PubMed ID: 16353981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying crystallisation rates of amorphous pharmaceuticals with dynamic mechanical analysis (DMA).
    Soutari N; Buanz AB; Gul MO; Tuleu C; Gaisford S
    Int J Pharm; 2012 Feb; 423(2):335-40. PubMed ID: 22101291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid form selection of zwitterionic 5-HT4 receptor agonist.
    Kojima T; Sugano K; Onoue S; Murase N; Sato M; Kawabata Y; Mano T
    Int J Pharm; 2008 Feb; 350(1-2):35-42. PubMed ID: 17919860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of moisture-sensitive drugs with aqueous polymer coatings: importance of coating and curing conditions.
    Bley O; Siepmann J; Bodmeier R
    Int J Pharm; 2009 Aug; 378(1-2):59-65. PubMed ID: 19477253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling Physical Stability of Amorphous Solids Based on Temperature and Moisture Stresses.
    Zhu DA; Zografi G; Gao P; Gong Y; Zhang GGZ
    J Pharm Sci; 2016 Sep; 105(9):2932-2939. PubMed ID: 27185539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative determination of solid-state forms of a pharmaceutical development compound in drug substance and tablets.
    Xie Y; Tao W; Morrison H; Chiu R; Jona J; Fang J; Cauchon N
    Int J Pharm; 2008 Oct; 362(1-2):29-36. PubMed ID: 18588963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermodynamics of water-solid interactions in crystalline and amorphous pharmaceutical materials.
    Sacchetti M
    J Pharm Sci; 2014 Sep; 103(9):2772-2783. PubMed ID: 24327540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Physical ageing of amorphous polymeric excipients III. The possible consequences of ageing].
    Zelkó R; Kiss D
    Acta Pharm Hung; 2006; 76(2):105-13. PubMed ID: 17094669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.